Skip to content

Prospective randomised trial of the surface cytology of 3 different single piece acrylic intraocular lenses (IOL)

Prospective randomised trial of the surface cytology of 3 different single piece acrylic intraocular lenses (IOL)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN64865132
Enrollment
Unknown
Registered
2005-09-30
Start date
2002-10-31
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Eye Surgery Eye

Interventions

IOL Acrysof vs two new acrylic IOLs recently approved for use in the UK, Centreflex and Akreso-fit

Sponsors

Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are undergoing routine cataract surgery without pre-existing ocular of systemic disease.

Exclusion criteria

Exclusion criteria: Pre-existing ocular or systematic disease which may interfere with their post-operative inflammatory course, including diabetic retinopathy, glaucoma, uveitis, pseudoexfloiation, previous eye surgery, contralateral surgery in the previous 4 months, extremes of age (90 years), significant macular degeneration or amblyopia precluding a post-operative vision of >6/12, mature cataracts requiring Visual Blue for extraction.

Design outcomes

Primary

MeasureTime frame
Understanding the biocompatibility of these IOLs will enable surgeons to ascertain whether these IOLs are safe for use in all cases, and also whether there are any unexpected complications that may arise on extended analysis such as this.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026